Teleflex to Participate in the 33rd Annual Virtual Piper Sandler Healthcare Conference
Teleflex Incorporated (NYSE: TFX) is participating in the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 22 to December 2, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Teleflex Incorporated (NYSE: TFX) is participating in the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 22 to December 2, 2021. A pre-recorded presentation will be available on their investor website at 10 AM ET on November 22. Additionally, 1x1 meetings are scheduled for December 2, which can be requested through Piper Sandler. Teleflex focuses on innovative medical technologies across various fields including vascular access and emergency medicine, aiming to enhance patient health and quality of life.
Details
News Market Reaction – TFX
The recorded move for TFX in the trading session of this news was -2.81%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WAYNE, Pa., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Thomas Powell, Executive Vice President and CFO, Teleflex Incorporated (NYSE: TFX), is pleased to participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference. From November 22nd to December 2nd, 2021, registered attendees can access a pre-recorded presentation via the Piper Sandler conference site. Teleflex will be participating in 1x1 meetings on December 2, 2021. Investor meetings can be requested exclusively via Piper Sandler.
The pre-recorded conference presentation will be made available on the investor section of the Teleflex website at teleflex.com at 10am ET on Monday, November 22nd.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.
Contacts:
Teleflex Incorporated:
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
John Hsu, CFA
Vice President, Investor Relations
investors.teleflex.com
610-948-2836
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.